FDA approval will help, as will insurer adoption of Galleri, but the price that they might be willing to pay for the test is also critical.

If it grows at the rate it's grown over the past three years, your stake could end up worth over $400,000! (But closer to $38 ...

At this point, many retirees are busy enjoying October, whether it means going to farmers' markets, hiking among the changing ...

Nvidia ( NVDA -0.52%) likely won't post its fiscal third-quarter results until November. Last year, the artificial ...

But as winter approaches, natural gas prices will likely climb even higher as temperatures drop and heating costs rise. To ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol ...

Arm commands smartphone architecture and is moving into AI CPUs; Marvell dominates data center connectivity with 32.6% net ...

That means there's still a lot more growth ahead for CoreWeave, while Amazon will continue to enjoy modest revenue growth (at ...

Social Security's cost-of-living adjustment (COLA) for 2027 is expected to be announced Oct. 14. What might it mean for you?

Some of the world's most important artificial intelligence (AI) stocks are noticeably absent from the S&P 500.

Firefly's hypergrowth masks massive cash burn, while Rocket Lab trades at a premium despite better financial discipline. One ...